$ROIV

$37.74▲ -1.3% YTD

7 SEC 13D/G filings tracked · Last updated Sep 23, 2026

Filing History

CP $37.74▲ -1.3%Sep 23, 2026 · ThinkSabio Blog

$ROIV ROIVW - Roivant Announces Topline Results from Proof-of-Concept Study of IMVT-1402 in Cutaneous Lupus Erythematosus…

News

ROIV ▲ +2.5% - Roivant Sciences Ltd.

CP $35.79▲ +2.5%Sep 8, 2026 · ThinkSabio Blog

$ROIV ROIVW - Roivant Announces Positive Results from PHocus Study of Mosliciguat in Patients with Pulmonary Hypertension Associated with Interstitial…

News

ROIV ▲ +2.6% - Roivant Sciences Ltd.

CP $35.31▲ +2.6%Sep 6, 2026 · ThinkSabio Blog

$ROIV ROIVW - Roivant to Present Topline Results from the Phase 2 PHocus Study of Mosliciguat in Patients with Pulmonary Hypertension Associated with…

News

ROIV ▲ +1.6% - Roivant Sciences Ltd.

CP $37.33▲ +1.6%Aug 27, 2026 · ThinkSabio Blog

$ROIV ROIVW - Roivant Announces FDA Approval of LISRAYA™ (brepocitinib) for Adults with Dermatomyositis; Now Available in the U.S…

News

ROIV ▲ +1.6% - Roivant Sciences Ltd.

CP $37.33▲ +1.6%Aug 27, 2026 · ThinkSabio Blog

$ROIV ROIVW - Priovant Announces FDA Approval of LISRAYA™ (brepocitinib) for Adults with Dermatomyositis; Now Available in the U.S…

News

ROIV ▲ +1.6% - Roivant Sciences Ltd.

CP $37.33▲ +1.6%Aug 27, 2026 · ThinkSabio Blog

$ROIV highs continue off FDA earlier release…

SEC 13D/G

ROIV - Roivant Sciences Ltd. - SEC Filing Update (13-AUG-2026) | ThinkSabio - Stocks Simplified

$36.28▲ 65.51%Aug 13, 2026 · ThinkSabio Blog

$ROIV SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #ROIV Roivant Sciences Ltd. : $36.28 Sector: Healthcare | YTD: 🔼…